PlainRecalls
FDA Drug Moderate Class II Terminated

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30

Reported: August 24, 2016 Initiated: June 30, 2016 #D-1457-2016

Product Description

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30

Reason for Recall

Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

Details

Recalling Firm
Actavis Inc
Units Affected
167,152 bottles
Distribution
Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30. Recalled by Actavis Inc. Units affected: 167,152 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2016. Severity: Moderate. Recall number: D-1457-2016.